SymBio Pharmaceuticals Limited
SYMQY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $23 | $3,054 | $3,615 | $3,963 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $205 | $212 | $423 |
| Inventory | $2 | $275 | $257 | $238 |
| Other Curr. Assets | $4 | $562 | $545 | $300 |
| Total Curr. Assets | $31 | $4,096 | $4,628 | $4,924 |
| Property Plant & Equip (Net) | $0 | $37 | $37 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $38 | $0 | $44 |
| Tax Assets | $0 | $6 | $2 | $0 |
| Other NC Assets | $0 | -$38 | $0 | $0 |
| Total NC Assets | $0 | $43 | $39 | $44 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $31 | $4,139 | $4,667 | $4,968 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $99 | $62 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $371 | $502 | $766 |
| Total Curr. Liab. | $4 | $470 | $565 | $766 |
| LT Debt | $16 | $1,300 | $700 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $5 | $5 | $7 |
| Total NC Liab. | $16 | $1,305 | $705 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $20 | $1,775 | $1,269 | $773 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $128 | $18,598 | $18,588 | $18,336 |
| Retained Earnings | -$245 | -$35,055 | -$34,007 | -$32,685 |
| AOCI | $2 | $0 | $344 | $322 |
| Other Equity | $127 | $18,821 | $18,473 | $18,222 |
| Total Equity | $11 | $2,364 | $3,398 | $4,195 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $31 | $4,139 | $4,667 | $4,968 |
| Net Debt | -$8 | -$1,754 | -$2,915 | -$3,963 |